PSYCHED THERAPEUTICS
DEAD

Serial Number

79353227

Owner

Psyched Therapeutics Limited

Filing Date

Aug 31, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PSYCHED THERAPEUTICS Trademark

Serial Number: 79353227

PSYCHED THERAPEUTICS is a trademark filed by Psyched Therapeutics Limited on August 31, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Psyched Therapeutics Limited

Coliemore House,

Entity Type: 98

Trademark Details

Filing Date

August 31, 2022

Registration Date

Not Registered

Goods & Services

Medical and veterinary preparations; pharmaceuticals and natural remedies; pharmaceuticals; psychotropics; pharmaceutical preparations for human use

Human healthcare services; medical services; alternative medicine services; medical clinic services; medical analysis for the diagnosis and treatment of persons; medical counseling; medical care and analysis services relating to patient treatment; individual medical counseling services provided to patients; counselling relating to the psychological treatment of medical ailments; counselling relating to the psychological relief of medical ailments; psychological care; psychological counseling; psychological examination; psychological testing for medical purposes; provision of information relating to psychology; providing psychological treatment; psychological treatment; psychotherapy services

Scientific and technological services; medical and pharmacological research services; medical research; testing, authentication and quality control; scientific research for medical purposes; biological research, clinical research and medical research; consultancy relating to research and development in the field of therapeutics; medical laboratory services; consultancy in the field of pharmaceutical research; medical research laboratory services; laboratory research services relating to pharmaceuticals; pharmaceutical product evaluation; consultancy pertaining to pharmacology; clinical trials; testing of pharmaceuticals; clinical research; pharmaceutical research and development; pharmaceutical drug development services; consultancy relating to pharmaceutical research and development; conducting early evaluations in the field of new pharmaceuticals; conducting clinical trials for pharmaceutical products

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 3, 2025 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Apr 14, 2025 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 14, 2025 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 28, 2024 NREP
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 12, 2024 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 12, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 12, 2024 ABN2
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 8, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 20, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 20, 2024 OPNR
REFUSAL PROCESSED BY IB
Oct 24, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 29, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 29, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 19, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 18, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 11, 2023 DOCK
ASSIGNED TO EXAMINER
Jun 20, 2023 DOCK
ASSIGNED TO EXAMINER
Jun 16, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 25, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 20, 2022 REPR